Mitchell Capital Management Co. Has $313,000 Stake in Mettler-Toledo International, Inc. $MTD

Mitchell Capital Management Co. trimmed its holdings in Mettler-Toledo International, Inc. (NYSE:MTD) by 13.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 262 shares of the medical instruments supplier’s stock after selling 39 shares during the period. Mitchell Capital Management Co.’s holdings in Mettler-Toledo International were worth $313,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the company. Greenleaf Trust lifted its holdings in Mettler-Toledo International by 1.2% during the 1st quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier’s stock worth $1,030,000 after purchasing an additional 10 shares during the last quarter. Brooklyn Investment Group increased its stake in Mettler-Toledo International by 12.8% during the 1st quarter. Brooklyn Investment Group now owns 88 shares of the medical instruments supplier’s stock worth $104,000 after acquiring an additional 10 shares during the period. Sax Wealth Advisors LLC increased its stake in Mettler-Toledo International by 2.8% during the 2nd quarter. Sax Wealth Advisors LLC now owns 372 shares of the medical instruments supplier’s stock worth $437,000 after acquiring an additional 10 shares during the period. Sequoia Financial Advisors LLC increased its stake in Mettler-Toledo International by 1.8% during the 1st quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier’s stock worth $740,000 after acquiring an additional 11 shares during the period. Finally, Albion Financial Group UT increased its stake in Mettler-Toledo International by 1.5% during the 1st quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier’s stock worth $890,000 after acquiring an additional 11 shares during the period. 95.07% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. Bank of America lifted their price target on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research note on Monday, September 22nd. Weiss Ratings reiterated a “hold (c)” rating on shares of Mettler-Toledo International in a research note on Wednesday, October 8th. Barclays lifted their price target on Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the company an “overweight” rating in a research note on Thursday, October 2nd. Robert W. Baird lifted their price target on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a “neutral” rating in a research note on Monday, August 4th. Finally, JPMorgan Chase & Co. lifted their price target on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a research note on Thursday. Five equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $1,336.50.

Insiders Place Their Bets

In other Mettler-Toledo International news, Director Thomas P. Salice sold 1,062 shares of Mettler-Toledo International stock in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the transaction, the director directly owned 283 shares of the company’s stock, valued at approximately $368,154.70. The trade was a 78.96% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Gerry Keller sold 165 shares of Mettler-Toledo International stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total value of $215,925.60. Following the transaction, the insider directly owned 94 shares in the company, valued at $123,012.16. The trade was a 63.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 1,827 shares of company stock valued at $2,371,208. 0.77% of the stock is currently owned by company insiders.

Mettler-Toledo International Stock Down 2.5%

Shares of MTD stock opened at $1,274.39 on Monday. The firm has a market capitalization of $26.25 billion, a P/E ratio of 32.27, a P/E/G ratio of 3.82 and a beta of 1.37. Mettler-Toledo International, Inc. has a twelve month low of $946.69 and a twelve month high of $1,486.76. The stock’s fifty day simple moving average is $1,278.97 and its 200 day simple moving average is $1,190.01.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, topping analysts’ consensus estimates of $9.58 by $0.51. The business had revenue of $983.22 million for the quarter, compared to analyst estimates of $957.41 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.Mettler-Toledo International’s quarterly revenue was up 3.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $9.65 EPS. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, equities research analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.